Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785038 · ClinicalTrials.gov registry record · NA
Encouraging Multiple PrEP Options for Women Engaged in PRimary Care
A NA study of PrEP Education, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06785038 is a NA study of PrEP Education that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06785038, a NA study of PrEP Education, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will address the significant yet often overlooked problem of HIV among cisgender women. To do this, researchers will adapt and test a multilingual technology-based strategy supporting informed decision-making for PrEP in primary care. Specifically, researchers will use the electronic health record to securely send women multimedia educational materials in English or Spanish about PrEP, and facilitate electronic scheduling of PrEP visits - if women decide they are interested. Choice is critical.
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL EMPOWER Strategy
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06785038
The ClinicalTrials.gov registry entry for NCT06785038 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PrEP Education appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT06785038 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06785038 about?
NCT06785038 is a clinical study titled "Encouraging Multiple PrEP Options for Women Engaged in PRimary Care". This study will address the significant yet often overlooked problem of HIV among cisgender women. To do this, researchers will adapt and test a multilingual technology-based strategy supporting informed decision-making for PrEP in primary care. Specifically, researchers will use the electronic heal...
What is the current status of trial NCT06785038?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-19. Estimated completion is 2026-07-31.
What conditions does trial NCT06785038 study?
This clinical trial studies the following conditions: PrEP Education.
What interventions are being tested in trial NCT06785038?
The interventions under investigation include: Attention Control (BEHAVIORAL), EMPOWER Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06785038?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785038 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.